Bunkerhill Health vs Magentiq Eye

Bunkerhill's homepage sells a long-horizon AI agent to health systems. It handles referral queue prioritization, oral-oncolytic prior authorization and heart failure follow-up, and its cleared algorithms include CAC, AVC, BMD and abdominal aortic quantification. UTMB Health's chief AI officer is the quoted customer, which is a vendor testimonial. The trust page lists SOC 2 Type II, HIPAA and ISO 27001:2022, and pricing runs through a demo request.

Magentiq targets the endoscopy unit. MAGENTIQ-COLO takes video from the endoscopy tower, works with Olympus, Fujinon, Pentax and Sonoscape systems, and highlights polyps in real time with bounding boxes. It comes as a processor-only unit or cart on monthly rental, and PENTAX Medical expanded its agreement with Magentiq to include integration into Pentax video processors. A Lancet Digital Health randomized tandem trial across 10 hospitals and 916 patients found 0.70 adenomas per colonoscopy against 0.51 conventionally. Magentiq Eye funded it, several authors report consultancy, stock options or equipment from Magentiq, and the abstract does not name the product.

Bunkerhill is an agent platform for a health system's AI office and Magentiq is a colonoscopy add-on, which gives each its own buyer.